Lung cancer (small cell)
Do you want to receive a message when there is new research about Small Cell Lung Cancer (SCLC)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you see one sentence explaining what was studied — and you'll be notified as soon as there is new research about Small cell lung cancer. View what Premium costs.
Publications (2657)
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Is the prognostic nutritional index a prognostic and predictive factor in metastatic non-small cell lung cancer patients treated with first-line chemotherapy? (2020/05/01) ♡
- Ceritinib-associated hyperglycemia in the Japanese Adverse Drug Event Report Database. (2020/05/01) ♡
- Prognostic Variables Associated With Improved Outcomes in Patients With Stage III NSCLC Treated With Chemoradiation Followed by Consolidation Pembrolizumab: A Subset Analysis of a Phase II Study From the Hoosier Cancer Research Network LUN 14-179. (2020/05/01) ♡
- Combination of Gentiana rhodantha and Gerbera anandria in the BL02 formula as therapeutics to non-small cell lung carcinoma acting via Rap1/cdc42 signaling: A transcriptomics/ bio-informatics biological validation approach. (2020/05/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy and safety of Shengjiang Xiexin decoction in prophylaxis of chemotherapy-related diarrhea in small cell lung cancer patients: study protocol for a multicenter randomized controlled trial. (2020/05/01) ♡
- Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early-stage non-small cell lung cancer. (2020/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatocellular carcinoma-derived exosomes in organotropic metastasis, recurrence and early diagnosis application. (2020/05/01) ♡
- The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics. (2020/05/01) ♡
- Evaluation of nutritional status in non-small-cell lung cancer: screening, assessment and correlation with treatment outcome. (2020/05/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A rare cause of sudden chest pain and dyspnea: A CARE-compliant case report of Chilaiditi syndrome. (2020/05/01) ♡
- A Shallow Convolutional Neural Network Predicts Prognosis of Lung Cancer Patients in Multi-Institutional CT-Image Data. (2020/05/01) ♡
- Pretreatment nutritional status and response to checkpoint inhibitors in lung cancer. (2020/04/24) ♡
- Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. (2020/04/23) ♡
- Profiling of subcellular EGFR interactome reveals hnRNP A3 modulates nuclear EGFR localization. (2020/04/22) ♡
- Wild and Cultivated Centaurea raphanina subsp. mixta: A Valuable Source of Bioactive Compounds. (2020/04/15) ♡
- Identification of a novel tumor angiogenesis inhibitor targeting Shh/Gli1 signaling pathway in Non-small cell lung cancer. (2020/04/14) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The effect of comprehensive rehabilitation program plus chemotherapy on quality of life in patients with postoperative non-small-cell lung cancer: study protocol of a multicenter randomized clinical trial. (2020/04/03) ♡
- Identification of microRNAs in skeletal muscle associated with lung cancer cachexia. (2020/04/01) ♡
- Ellagitannins from Punica granatum leaves suppress microsomal prostaglandin E synthase-1 expression and induce lung cancer cells to undergo apoptosis. (2020/04/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Commentary: The checkpoint before checkpoint inhibitors. (2020/04/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Commentary: Breaking down non-small cell lung cancer tumor microenvironment heterogeneity and predicting response to immune checkpoint inhibitors. (2020/04/01) ♡
- The impact of WeChat app-based education and rehabilitation program on anxiety, depression, quality of life, loss of follow-up and survival in non-small cell lung cancer patients who underwent surgical resection. (2020/04/01) ♡
- Luteolin attenuates migration and invasion of lung cancer cells via suppressing focal adhesion kinase and non-receptor tyrosine kinase signaling pathway. (2020/04/01) ♡
- Survival Analysis for Patients with ALK Rearrangement-Positive Non-Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401. (2020/04/01) ♡
- Immune-Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non-Small Cell Lung Cancer. (2020/04/01) ♡
- Identification of a novel PAK1 inhibitor to treat pancreatic cancer. (2020/04/01) ♡
- Modified Liujunzi Decoction () Alleviates Chemotherapy-Induced Anorexia in Advanced Non-Small Cell Lung Cancer: A Propensity Score Matched Case-Control Study. (2020/04/01) ♡
- Aloperine in combination with therapeutic adenoviral vector synergistically suppressed the growth of non-small cell lung cancer. (2020/04/01) ♡
- Antiproliferative and Antimetastatic Effects of Praeruptorin C on Human Non-Small Cell Lung Cancer Through Inactivating ERK/CTSD Signalling Pathways. (2020/04/01) ♡
- Handgrip weakness, low fat-free mass, and overall survival in non-small cell lung cancer treated with curative-intent radiotherapy. (2020/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. [Enteral nutrition in malnourished patients with lung cancer]. (2020/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Tracheoesophageal fistula associated with bevacizumab after thoracic radiotherapy in non-small cell lung cancer: A case report. (2020/04/01) ♡
- The impact of immune-inflammation-nutritional parameters on the prognosis of non-small cell lung cancer patients treated with atezolizumab. (2020/04/01) ♡
- In-vitro Studies of Anti-EGFR Tyrosine Kinase Activity of Thai nutraceutical Plants. (2020/04/01) ♡
- First-Line Therapy for Metastatic Non-Small Cell Lung Cancer: State-of-the-Art Targeted Therapy and Immunotherapy Approaches. (2020/04/01) ♡
- Psoriasiform Dermatitis Related with T-Cell Immunoreceptor with Immunoglobulin and Immunoreceptor Tyrosine-Based Inhibitory Motif Domains Inhibitor in a Patient with Non-Small-Cell Lung Cancer. (2020/04/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. In Vivo Imaging of Mitochondrial Membrane Potential in Non-Small Cell Lung Cancer. (2020/03/27) ♡
- Myasthenia gravis and concurrent myositis following PD-L1 checkpoint inhibitor for non-small cell lung cancer. (2020/03/19) ♡
- A shift in glutamine nitrogen metabolism contributes to the malignant progression of cancer. (2020/03/17) ♡
- Low Prognostic Nutritional Index Predicts Poor Clinical Outcomes in Patients with Stage IIIB Non-small-cell Lung Carcinoma Undergoing Chemoradiotherapy. (2020/03/16) ♡
- Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo. (2020/03/15) ♡
- Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer. (2020/03/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Treatment of epidermal growth factor receptor inhibitor-induced severe paronychia with pyogenic granuloma-like lesions with topical betaxolol: an open-label observation study. (2020/03/01) ♡
- Low pretreatment PNI correlates with worse survival in patients with stage III/IV NSCLC who received chemotherapy. (2020/03/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Five-year survival and prognostic factors according to histology in 6101 non-small-cell lung cancer patients. (2020/03/01) ♡
- Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50. (2020/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Is there a place for crizotinib in c-MET alterations? A case of efficacy in ALK positive NSCLC patient with secondary c-MET amplification. (2020/03/01) ♡
- Knockdown of TOR signaling pathway regulator suppresses cell migration and invasion in non-small cell lung cancer via the regulation of epithelial-to-mesenchymal transition. (2020/03/01) ♡
- Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti-Programmed Cell Death 1 Monotherapy for Advanced Non-Small Cell Lung Cancer. (2020/03/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Phase II Study on Biweekly Combination Therapy of Gemcitabine plus Carboplatin for the Treatment of Elderly Patients with Advanced Non-Small Cell Lung Cancer. (2020/03/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.